Markus Haeberlein

Technik-/Wissenschafts-/F&E-Leiter bei ALKERMES PLC

Health Technology

Consumer Services

Aktive Positionen von Markus Haeberlein

Unternehmen	Position	Beginn	Ende
ALKERMES PLC	Technik-/Wissenschafts-/F&E-Leiter	-	-

Unternehmen	Position	Beginn	Ende
AstraZeneca LP AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE.	Direktor/Vorstandsmitglied	-	-
	Corporate Officer/Principal	-	-
PROTEOSTASIS THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2012	-

Royal Institute of Technology

Doctorate Degree

International

Operativ

Chief Tech/Sci/R&D Officer	2
Director/Board Member	1
Corporate Officer/Principal	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ALKERMES PLC	Health Technology

Private Unternehmen	2
Proteostasis Therapeutics, Inc. Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.	Health Technology
AstraZeneca LP AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE.	Health Technology

Private Unternehmen

Health Technology